Tag Archives: Results

Frieden, Birx discuss the catastrophe, warning of Ebola in last year

By on .

At this time last year, Ebola had been reported in West Africa for six months, and in Liberia and Sierra Leone the number of new cases was doubling every few weeks. In Nigeria, where a man sick with the virus had landed in the capital city three months earlier and sparked an outbreak culminating in 20 cases, the epidemic […]

AIDS 2014: TB HIV goals closer to rhetoric than reality, report released here shows

By on .

Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia through the week, with updates on research, policy and insights from the 20th International AIDS Conference.   MELBOURNE, AUSTRALIA – While tuberculosis remains the leading killer of people with HIV, measures targeting the two diseases together remain neglected by HIV programs, leaving the bulk of […]

TB treatment advocates to Sanofi pharmaceutical company on drug price: “We cry enough!”

By on .

A little more than four months ago, a collection of organizations and individuals concerned with the high price of rifapentine, a drug that could treat tuberculosis more quickly than other drugs, and also treat TB infection before it caused illness, wrote to Sanofi, the company that makes the medicine. Noting that government funding that had […]

US TB drug shortages highlight global gaps

By on .

This is how small the world of infectious diseases can be, and how recent the distant past. The patient who ended up at Baltimore’s Health Department in April 2011 had been treated with apparent success for tuberculosis before, in Kenya, where he was from. But now, he had a strain of the disease that was […]

Research, TB and the Robin Hood tax, harm reduction results, and more research . . .

By on .

Px Wire: AVAC’s Quarterly Update on HIV Prevention Research includes great graphics, spells out clear definitions (i.e. “the purpose of sieve analysis,” is similar to what it sounds like), interesting updates — the latest yield from the Thai 144 AIDS vaccine trial, and vaginal microbicide ring research — including findings showing protection among 83 percent […]

India’s patent laws, public health response without public healthcare and bridging the Global Fund gap . . .

By on .

India’s patent laws: This Lancet special report on legal challenges by Bayer and Novartis to applications of India’s Patents Act provides a link to the 2010 United Nations Development Program’s report on the nation’s efforts to supply affordable HIV treatment in the context of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). It […]